BIO-key International (BKYI) to Release Quarterly Earnings on Thursday

BIO-key International (NASDAQ:BKYI) is anticipated to announce its Q4 2025 results before the market opens on Thursday, March 26th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $2.20 million for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, March 27, 2026 at 12:30 PM ET.

BIO-key International Trading Up 2.7%

NASDAQ:BKYI opened at $0.66 on Thursday. BIO-key International has a 52-week low of $0.51 and a 52-week high of $1.97. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. The stock has a fifty day simple moving average of $0.63 and a 200-day simple moving average of $0.71. The company has a market capitalization of $7.16 million, a PE ratio of -0.63 and a beta of 0.41.

Institutional Trading of BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC increased its position in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. 26.51% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

BKYI has been the subject of several recent research reports. Wall Street Zen upgraded shares of BIO-key International to a “sell” rating in a report on Saturday, January 3rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, BIO-key International presently has an average rating of “Sell”.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.